Kenneth W. Kizer, M.D., M.P.H. (Chair), is a distinguished professor at the University of California (UC), Davis, School of Medicine and the Betty Irene Moore School of Nursing; the director of the Institute for Population Health Improvement, UC Davis Health System; the director of the California Cancer Reporting and Epidemiologic Surveillance Program; and the chief quality consultant for the California Department of Health Care Services. Dr. Kizer’s professional experience includes senior executive positions in the public and private sectors, academia, and philanthropy. His previous positions have included chairman, chief executive officer, and president, Medsphere Systems Corporation; founding president and chief executive officer, National Quality Forum; undersecretary for health, Department of Veterans Affairs; director, California Department of Health Services; and director, California Emergency Medical Services Authority. He has served on the U.S. Preventive Services Task Force and as chairman of the California Wellness Foundation as well as on the governing boards of a number of health information technology and managed care companies, several foundations, and various professional associations and nonprofit organizations. Dr. Kizer is an honors graduate of Stanford University and the University of California, Los Angeles, and the recipient of two honorary doctorates. He is board certified in six medical specialties and subspecialties and has authored more than 400 original articles, book chapters, and other reports. He is a fellow or distinguished fellow of 10 professional societies and is a member of the National Academy of Public
Administration in addition to the National Academy of Medicine. He has served on numerous National Academies’ committees.
James M. Anderson, M.D., Ph.D., is a distinguished university professor and a professor of pathology, macromolecular science, and biomedical engineering at Case Western Reserve University in Ohio. Dr. Anderson has worked in the area of biomaterials, medical devices, and prostheses for more than 40 years. His current research activities range from the clinical pathology evaluation of retrieved implants from humans to fundamental studies of cellular interactions with biomaterials. Dr. Anderson is the recipient of a National Institutes of Health (NIH) MERIT Award (1993 to 2003). He is a founding member of the Society for Biomaterials and the Controlled Release Society and serves as a consultant to the NIH Artificial Heart Program, the Food and Drug Administration, and the International Organization for Standardization (ISO) where he is the co-chair of Working Group 1 for the development of the ISO Standard on Biological Evaluation of Medical Devices. He is the editor-in-chief of the Journal of Biomedical Materials Research. In 2005, Dr. Anderson received the Elsevier Biomaterials Gold Medal Award, which is awarded to the individual who has made the most significant contributions to biomaterials science over the 25-year period from 1980 to 2005. Dr. Anderson is the recipient of the Chugai Mentoring Award and the Honoris Causa Degree (honorary doctorate of philosophy degree) by the University of Geneva, Switzerland. In 2008, Dr. Anderson was elected to the American Association of Physicians, and he was elected a fellow of the American Association for the Advancement of Science in 2011. He is also the recipient of the 2013 Acta Biomaterialia Gold Medal for his contributions to biomaterial science and engineering. He is a graduate of Oregon State University (Ph.D.) and Case Western Reserve University School of Medicine (M.D.), and he finished his anatomic pathology residency at the Institute of Pathology of University Hospitals of Cleveland. He has previously served on three National Academies committees and is currently a member of the Panel on Life Sciences. Dr. Anderson is also a member of the National Academy of Engineering (2013) and the National Academy of Medicine (2003).
Marjorie A. Bowman, M.D., is a professor and the director for health sciences research at the Wright State Research Institute and a former dean of the Boonshoft School of Medicine at Wright State University in Ohio. She has previously worked in the Department of Health and Human Services, specializing in health policy, and she served as a commissioned officer in the U.S. Public Health Service. At the Georgetown University School of Medicine she served as assistant dean, responsible for continuing medical education, affiliations with other institutions and the government of
Washington, DC, and as division director for family medicine. She has chaired clinical departments in Wake Forest University School of Medicine and the University of Pennsylvania School of Medicine. Dr. Bowman has served as a consultant to several branches of government and many universities and is widely published in areas of behavior change, health personnel, women’s health, and community health. She currently edits the Journal of the American Board of Family Medicine, which has championed patient-centered medical homes. She has published more than 200 articles and publications. Her recent research projects explored community health interventions, lifestyle change for chronic diseases, and the use of mixed methods to tackle health system and chronic disease problems. Dr. Bowman is a graduate of Jefferson Medical College (M.D.) and the University of Southern California (M.P.A.). She completed her residency in family medicine at Duke University Medical Center. She has been involved with several National Academies activities and is a member of the National Academy of Medicine (1993).
Marina Broitman, Ph.D., is a senior program officer of peer review at the Patient-Centered Outcomes Research Institute (PCORI) in Washington, DC. In this role, Dr. Broitman manages PCORI’s peer review program, which is the process PCORI uses to ensure that its funded research has high scientific integrity, adheres to PCORI’s methodology standards, and is relevant and useful to patients and stakeholders. Dr. Broitman’s previous position at PCORI was as senior merit review officer. Before joining PCORI, she served as a scientific review officer and an associate referral liaison at the National Institute of Mental Health (NIMH) for more than 10 years, where she oversaw scientific review of grant applications. In both PCORI’s merit review and in NIMH’s scientific review, Dr. Broitman’s review panels focused on comparative effectiveness research and health services research. Dr. Broitman has been engaged for several years in the recruitment and training of scientific, patient, and other stakeholder reviewers for scientific merit reviews. She also has substantial experience in working with scientific and administrative staff at both funding agencies in developing new policies, standard operating procedures, and initiatives around peer review. Dr. Broitman received her Ph.D. from George Washington University.
Carl A. Castro, Ph.D., is an associate professor at the University of Southern California School of Social Work and also serves as the director of the Center for Innovation and Research on Veterans and Military Families. Dr. Castro joined the faculty in 2013 after retiring as a colonel from the U.S. Army, where he served for 33 years. He served in a variety of research and leadership positions, including as the director of the Military Opera-
tional Medicine Research Program and the U.S. Army Medical Research and Materiel Command at Fort Detrick, Maryland. Dr. Castro completed two tours in Iraq as well as peacekeeping missions to Bosnia, Kosovo, and Saudi Arabia. He is currently chair of a NATO research group on military veteran transitions, a Fulbright Scholar, and member of several Department of Defense research advisory panels focused on psychological health. He is the current editor of Military Behavioral Health, the flagship academic journal about the biopsychosocial health and well-being of service members, veterans, and military families. Dr. Castro has authored more than 150 scientific articles and reports in numerous research areas. His current research efforts focus on assessing the effects of combat and operations tempo on soldier, family, and unit readiness and evaluating the process of service members’ transitions from military to civilian life. Dr. Castro has previously served on many CDMRP program review boards and currently holds a CDMRP grant previously awarded in 2014, prior to the start of this study. He is a graduate of the University of Colorado (M.A. and Ph.D.). Dr. Castro currently serves on the National Academies’ Board on Army Science and Technology.
Kay Dickersin, Ph.D., serves as the director for the Center for Clinical Trials and Evidence Synthesis at Johns Hopkins University. She is also the director of the U.S. Cochrane Center (USCC), 1 of 13 centers worldwide participating in the Cochrane Collaboration, which aims to help people make well-informed decisions about health by preparing, maintaining, and promoting the accessibility of systematic reviews of the available evidence on the benefits and risks of health care. The USCC hosts Consumers United for Evidence-Based Healthcare. Dr. Dickersin also serves as the director of the Cochrane Eyes and Vision Review Group, U.S. Satellite. Dr. Dickersin’s major research interests are related to epidemiology, randomized clinical trials, systematic reviews and meta-analysis, reporting biases, trials registers, peer review, evidence-based health care, and patient-centered outcomes research. She has conducted studies in a number of areas, including women’s health, eyes and vision, and surgery. Dr. Dickersin is a graduate of the University of California, Berkeley (B.A. and M.A.) and the Johns Hopkins University School of Hygiene and Public Health (Ph.D.). She has served on numerous National Academies committees, including the 1993 and 1997 committees that established the review process used by CDMRP, and she is a member of the National Academy of Medicine (2007).
Maha Hussain, M.D., FACP, FASCO, is the Genevieve Teuton Professor of Oncology and Professor of Medicine, Division of Hematology Oncol-
ogy, Department of Internal Medicine, Northwestern University Feinberg School of Medicine and the associate director for clinical research at Robert H. Lurie Comprehensive Cancer Center. She is an internationally renowned expert and clinical researcher in genitourinary oncology. Her research is focused on the development of novel therapeutics integrating scientific advances into clinical trials. Her work has contributed to improving the standards of care for metastatic prostate cancer. Dr. Hussain served in many scientific and leadership roles while previously at the University of Michigan (UM), including the associate director for clinical research and co-leader of the Prostate Cancer/Genitourinary Oncology Program at the UM Comprehensive Cancer Center and the associate chief for clinical research in the Division of Hematology/Oncology. At the national level, she has served in a variety of scientific and leadership roles and as a member and the chair of the programmatic panel of CDMRP’s Prostate Cancer Research Program, and she is also a past CDMRP grant recipient. She has served as a member and the chair of the U.S. Food and Drug Administration Oncology Drug Advisory Committee. She was a member of the National Cancer Institute’s (NCI’s) Cancer Biomarker Study Section and the NCI’s prostate cancer task force and currently serves as an executive advisory board member for several NCI-designated cancer centers. Since joining the American Society of Clinical Oncology (ASCO) in 1990, Dr. Hussain has served on numerous committees and boards and was the associate editor for Cancer.Net. She currently serves on the Clinical Practice Guidelines Committee and is a member of the ASCO board of directors. The author of more than 230 scholarly articles and book chapters, she serves or has served on the editorial boards for several national and international specialty publications. She is the recipient of several honors and awards, including being elected as a fellow of ASCO (2010), the UM Medical School’s League of Research Excellence, and the 2012 Clinical and Health Services Research award. In 2015, she received OncLive’s Giants of Cancer Care award in genitourinary cancer. She is a graduate of the University of Baghdad Medical School and did her residency and medical oncology fellowship at Wayne State University/Detroit Medical Center.
Vickie Mays, Ph.D., is the director of the University of California, Los Angeles (UCLA), Center on Bridging Research Innovation, Training, and Education on Minority Health Disparities Solutions, which conducts research on the use of technology in reducing health disparities in clinical disorders. She teaches courses on the health status and health behaviors of racial and ethnic minority groups, research ethics in biomedical and behavioral research in racial/ethnic minority populations, research methods in minority research, as well as courses on mental health services and
mental health policy. Professor Mays’s research primarily focuses on the mental and physical health disparities affecting racial and ethnic minority populations. Her mental health services research examines integrated care models for racial/ethnic minorities, availability, access and quality of mental health services for racial, ethnic, and sexual minorities. She is the co-principal investigator of the California Quality of Life Survey, a population-based study of more than 7,000 Californians on the prevalence of mental health and substance abuse disorders and the contextual factors associated with those disorders. She has served as a member of a number of boards and committees, including the American Psychological Association, the American College of Epidemiology, the Institute of Medicine, the American Public Health Association, and others. Dr. Mays has provided testimony to a number of Congressional committees and federal agencies on HIV, mental health, and health disparities research findings. She has received a number of awards, including one for her lifetime research on women and HIV from the American Foundation for AIDS Research, the Women and Leadership Award from the American Psychological Association, and several Distinguished Contributions for Research Awards. Dr. Mays received her doctorate from the University of Massachusetts at Amherst with postdoctoral studies at the Institute of Social Research, the University of Michigan, and the RAND Health Policy and an M.P.H. from the UCLA School of Public Health. She has served on three National Academies committees and the Board on the Health of Select Populations.
Relford (Chip) Patterson, M.D., M.P.H., is a preventive medicine physician. Since March 2016, Dr. Patterson has supported business development projects at Comprehensive Health Services, Inc. (CHSi) and currently serves as the medical director for a CHSi government-contracted shelter operation in South Florida. Prior to his work at CHSi, he served as the director of occupational medicine at Gannett Health Services, an affiliate of Cornell University. He also served as an institutional review board member for Cornell University. His expertise is in injury prevention and control, aerospace medicine, and medical surveillance for military operations. Previously, Dr. Patterson served as a senior policy analyst for the assistant secretary for defense (health affairs); an occupational medicine consultant in the Office of the Surgeon General of the U.S. Air Force (USAF); an assistant professor and the director of the Environmental and Occupational Health Division, Department of Preventive Medicine and Biometrics, at Uniformed Services University of the Health Sciences; and the assistant director of aeromedical services at Andrews Air Force Base. He is a graduate of Georgetown University Medical School (M.D.) and the Johns Hopkins University (M.P.H.) and completed his residency in
aerospace medicine at the USAF School of Aerospace Medicine at Brooks Air Force Base, Texas.
Barbara J. Turner, M.D., M.S.Ed., M.A., is the director of the Center for Research to Advance Community Health (ReACH), the James D. and Ona I. Dye Professor of Medicine at the University of Texas (UT) Health Science Center at San Antonio, and an adjunct professor at the UT School of Public Health. She was formerly the executive deputy editor of the Annals of Internal Medicine and a professor of medicine at the University of Pennsylvania. Dr. Turner is a practicing general internist and health services researcher focusing on vulnerable populations and health disparities using administrative databases to evaluate care. She has received grants from the National Institute on Drug Abuse, the Agency for Healthcare Research and Quality, the Robert Wood Johnson Foundation, the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration, and the Center for Substance Abuse Treatment, among others. Dr. Turner has more than 150 peer-reviewed publications and editorials and has directed several randomized clinical trials that use peer coaches to improve the receipt of needed cancer preventive services and to reduce risk of cardiovascular events in high-risk African Americans. She received her medical degree from the University of Pennsylvania.
Myrl Weinberg, M.A., is the immediate past chief executive officer of the National Health Council, the only organization that provides a united voice for the more than 133 million people with chronic diseases and disabilities and their families and caregivers. Her career has focused on health care delivery, medical research, long-term care, and related issues that affect people with chronic conditions. She has testified before Congress and federal regulatory bodies and is a frequent speaker on the patient perspective in health policy. Currently, Ms. Weinberg serves as convenor for the Better Business Bureau Wise Giving Alliance’s Convenings for Collaboration Initiative, and as a member of the Tuvuga International advisory board. Ms. Weinberg also has served on the National Library of Medicine’s board of regents’ Working Group on Clinical Trials, the Department of Health and Human Services’ National Advisory Council for Healthcare Research and Quality, the governing board of the International Alliance of Patients’ Organizations, the Center for Information and Study on Clinical Research Participation board of advisors, the Brookings Active Surveillance Implementation Council, the national advisory committee of the Robert Wood Johnson Foundation’s Aligning Forces for Quality program, and the Roche International Science and Eth-
ics Advisory Group. Ms. Weinberg has also served on several Institute of Medicine committees, including the Committee on the National Institutes of Health Research Priority-Setting Process and the Committee on Clinical Trial Registries; she has also served as a member of the National Academies’ Board on Health Sciences Policy.